A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Becton, Dickinson and Company (also referred to herein as "BD") was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form 10-K to "BD", "the Company", "we", "our" or "us" refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context. BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 21.9B | 21.8B | 20.2B | 19.4B | 18.9B | 19.1B |
| Net Income | 1.8B | 1.7B | 1.7B | 1.4B | 1.7B | 2.0B |
| EPS | $4.81 | $4.58 | $4.61 | $3.88 | $4.62 | $5.25 |
| Free Cash Flow | 2.6B | 2.7B | 3.1B | 2.1B | 1.5B | 2.9B |
| ROIC | 5.1% | 5.0% | 4.4% | 4.7% | 4.9% | 5.4% |
| Gross Margin | 46.1% | 45.4% | 45.2% | 42.2% | 44.9% | 45.1% |
| Debt/Equity | 0.88 | 0.82 | 0.86 | 0.66 | 0.72 | 0.76 |
| Dividends/Share | $3.29 | $3.27 | $2.99 | $2.86 | $2.74 | $2.55 |
| Operating Income | 2.7B | 2.6B | 2.4B | 2.1B | 2.3B | 2.3B |
| Operating Margin | 12.2% | 11.8% | 11.9% | 10.9% | 12.1% | 11.8% |
| ROE | 6.9% | 6.5% | 6.6% | 5.5% | 6.7% | 8.5% |
| Shares Outstanding | 362M | 367M | 370M | 367M | 365M | 381M |
BECTON DICKINSON & CO passes 4 of 9 quality checks, suggesting mixed fundamentals.
BECTON DICKINSON & CO trades at 32.3x trailing earnings, compared to its 15-year median P/E of 37.2x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 21.4x vs a median of 22.6x. The company's 5-year average ROIC is 4.9% with a gross margin of 44.6%. Total shareholder yield (dividends + buybacks) is 3.0%. At current prices, the estimated annualized return to fair value is +0.8%.
BECTON DICKINSON & CO (BDX) has a current P/E ratio of 32.3, compared to its historical median P/E of 37.2. The stock is currently considered Fair based on its historical valuation range.
BECTON DICKINSON & CO (BDX) has a 5-year average return on invested capital (ROIC) of 4.9%. This is below average and may indicate limited pricing power.
BECTON DICKINSON & CO (BDX) has a market capitalization of $56.3B. It is classified as a large-cap stock.
Yes, BECTON DICKINSON & CO (BDX) pays a dividend with a trailing twelve-month yield of 2.12%. The company also returns capital through share buybacks, with a buyback yield of 0.89%.
Based on historical P/E analysis, BECTON DICKINSON & CO (BDX) appears fair. The current P/E of 32.3 is 13% below its historical median of 37.2. The estimated fair value CAGR (P/E method) is 16.3%.
BECTON DICKINSON & CO (BDX) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
BECTON DICKINSON & CO (BDX) reported annual revenue of $21.8 billion in its most recent fiscal year, based on SEC EDGAR filings.
BECTON DICKINSON & CO (BDX) has a net profit margin of 7.7%. This is a modest margin.
BECTON DICKINSON & CO (BDX) generated $2.7 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
BECTON DICKINSON & CO (BDX) has a debt-to-equity ratio of 0.82. This indicates moderate leverage.
BECTON DICKINSON & CO (BDX) reported earnings per share (EPS) of $4.58 in its most recent fiscal year.
BECTON DICKINSON & CO (BDX) has a return on equity (ROE) of 6.5%. This indicates moderate shareholder returns.
BECTON DICKINSON & CO (BDX) has a 5-year average gross margin of 44.6%. This indicates decent pricing power.
The Ledger Terminal provides 19 years of financial data for BECTON DICKINSON & CO (BDX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
BECTON DICKINSON & CO (BDX) has a book value per share of $69.23, based on its most recent annual SEC filing.
No recent press releases.